Eam Investors, LLC Sage Therapeutics, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 03, 2018	SELL	$140.36 - $175.76 $2.56 Million - $3.2 Million	-18,221 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$152.15 - $192.33 $254,851 - $322,152	-1,675 Reduced 8.42%	18,221 $2.94 Million
Q4 2017 Feb 12, 2018	BUY	$60.72 - $167.34 $1.21 Million - $3.33 Million	19,896	19,896 $3.28 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.